Songmin Ying

Songmin Ying


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2013 in Nature Cell Biology
Verified
Journal Article
Closed access
SYSongmin Ying
Songmin Ying
SMSheroy Minocherhomji
Sheroy Minocherhomji
KCKok-Lung Chan
Kok-Lung Chan
TPTimea Palmai-Pallag
Timea Palmai-Pallag
Wai Kit ChuWai Kit Chu
Wai Kit Chu
IHIan D. Hickson
Ian D. Hickson

13 August 2018 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
HLHongwei Liao
Hongwei Liao
FJFang Ji
Fang Ji
THThomas Helleday
Thomas Helleday
SYSongmin Ying
Songmin Ying

20 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YWYouqian Wu
Youqian Wu
CZChao Zhang
Chao Zhang
XLXiaolan Liu
Xiaolan Liu
ZHZhengfu He
Zhengfu He
BSBing Shan
Bing Shan
HXhongguang xia
hongguang xia
Cancer expression of PD-L1 suppresses anti-tumor immunity. PD-L1 has emerged as a remarkable therapeutic target. However, the regulation of PD-L1 degradation is not understood. Here, we identify several compounds as inducers of PD-L1 degradation using a high-throughput drug screen. We find EGFR inhibitors promote PD-L1 ubiquitination and proteasomal degradation following GSK3α-mediated phosphorylation of Ser279/Ser283. We identify ARIH1 as the E3 ubiquitin ligase responsible for targeting PD-L1 to degradation. Overexpression of ARIH1 suppresses tumor growth and promotes cytotoxic T cell activation in wild-type, but not in immunocompromised mice, highlighting the role of ARIH1 in anti-tumor immunity. Moreover, combining EGFR inhibitor ES-072 with anti-CTLA4 immunotherapy results in an additive effect on both tumor growth and cytotoxic T cell activation. Our results delineate a mechanism of PD-L1 degradation and cancer escape from immunity via EGFR-GSK3α-ARIH1 signaling and suggest GSK3α and ARIH1 might be potential drug targets to boost anti-tumor immunity and enhance immunotherapies.

15 May 2022 in Cell Discovery
Verified
Journal Article
Open access
PDF file
ZSZhehua Shao
Zhehua Shao
YTYangxia Tan
Yangxia Tan
QSQingya Shen
Qingya Shen
LHLi Hou
Li Hou
BYBingpeng Yao
Bingpeng Yao
HSHuahao Shen
Huahao Shen
Chemokine receptors are a family of G-protein-coupled receptors with key roles in leukocyte migration and inflammatory responses. Here, we present cryo-electron microscopy structures of two human CC chemokine receptor–G-protein complexes: CCR2 bound to its endogenous ligand CCL2, and CCR3 in the apo state. The structure of the CCL2–CCR2–G-protein complex reveals that CCL2 inserts deeply into the extracellular half of the transmembrane domain, and forms substantial interactions with the receptor through the most N-terminal glutamine. Extensive hydrophobic and polar interactions are present between both two chemokine receptors and the Gα-protein, contributing to the constitutive activity of these receptors. Notably, complemented with functional experiments, the interactions around intracellular loop 2 of the receptors are found to be conserved and play a more critical role in G-protein activation than those around intracellular loop 3. Together, our findings provide structural insights into chemokine recognition and receptor activation, shedding lights on drug design targeting chemokine receptors.

23 December 2021 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
ZSZhehua Shao
Zhehua Shao
QSQingya Shen
Qingya Shen
BYBingpeng Yao
Bingpeng Yao
CMChunyou Mao
Chunyou Mao
LCLi-Nan Chen
Li-Nan Chen
HSHuahao Shen
Huahao Shen
Biased signaling of G protein-coupled receptors describes an ability of different ligands that preferentially activate an alternative downstream signaling pathway. In this work, we identified and characterized different N-terminal truncations of endogenous chemokine CCL15 as balanced or biased agonists targeting CCR1, and presented three cryogenic-electron microscopy structures of the CCR1–Gi complex in the ligand-free form or bound to different CCL15 truncations with a resolution of 2.6–2.9 Å, illustrating the structural basis of natural biased signaling that initiates an inflammation response. Complemented with pharmacological and computational studies, these structures revealed it was the conformational change of Tyr291 (Y2917.43) in CCR1 that triggered its polar network rearrangement in the orthosteric binding pocket and allosterically regulated the activation of β-arrestin signaling. Our structure of CCL15-bound CCR1 also exhibited a critical site for ligand binding distinct from many other chemokine–receptor complexes, providing new insights into the mode of chemokine recognition.

14 December 2018 in Respiratory Research
Verified
Journal Article
Open access
PDF file
HSHua Su
Hua Su
XXXiaoling Xu
Xiaoling Xu
CYChao Yan
Chao Yan
YSYangfeng Shi
Yangfeng Shi
YHYanjie Hu
Yanjie Hu
RZRuifeng Zhang
Ruifeng Zhang
Pulmonary arterial hypertension (PAH) is related to inflammation, and the lncRNA H19 is associated with inflammation. However, whether PDGF-BB-H19-let-7b-AT1R axis contributes to the pathogenesis of PAH has not been thoroughly elucidated to date. This study investigated the role of H19 in PAH and its related mechanism. In the present study, SD rats, C57/BL6 mice and H19−/− mice were injected with monocrotaline (MCT) to establish a PAH model. H19 was detected in the cytokine-stimulated pulmonary arterial smooth muscle cells (PASMCs), serum and lungs of rats/mice. H19 overexpression and knockdown experiments were also conducted. A dual luciferase reporter assay was used to explore whether let-7b is a sponge miRNA of H19, and AT1R is a novel target of let-7b. A CCK-8 assay and flow cytometry were used to analyse cell proliferation. The results showed that H19 was highly expressed in the serum and lungs of MCT-induced rats/mice, and H19 was upregulated by PDGF-BB in vitro. H19 upregulated AT1R expression via sponging miRNA let-7b following PDGF-BB stimulation. AT1R is a novel target of let-7b. Moreover, the overexpression of H19 and AT1R could facilitate PASMCs proliferation in vitro. H19 knockout protected mice from pulmonary artery remodeling and PAH following MCT treatment. Our study showed that H19 is highly expressed in MCT-induced rodent lungs and upregulated by PDGF-BB. The H19-let-7b-AT1R axis contributed to the pathogenesis of PAH by stimulating PASMCs proliferation. The H19 knockout had a protective role in the development of PAH. H19 may be a potential tar-get for the treatment of PAH.